You are here: Industry Insights > CDMO

News List

Recipharm to Build New Fill-Finish Facility in Morocco contractpharma
July 07, 2021
Investment of around $500M by the Moroccan Government to establish capacity and capability for the manufacturing of vaccines and biotherapeutics.
Recipharm selected to operate new fill/finish facility in Morocco cphi-online
July 07, 2021
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country
CPhI Webinar: How is M&A Shifting the Pharma Manufacturing Landscape? cphi-online
July 07, 2021
The broad scope of the pharmaceutical manufacturing landscape is making merger and acquisition activity in the sector ever more complex with several varying factors driving decisions, according to a recent CPhI Webinar sponsored by PharmaVentures.
Bora Group announce the rebranding of Yuta Health to Bora Health prnasia
July 06, 2021
Leading Taiwan, China-based contract development and manufacturing organization (CDMO) Bora Group today announced a name change for its subsidiary, currently Yuta Health, to Bora Health Inc. as part of an overall plan to integrate its distribution operati
Viralgen opens expanded AAV manufacturing facility in Spain firstwordpharma
July 06, 2021
The CDMO's fivefold capacity increase will provide early preclinical through to commercialisation support
Avid Bioservices Appoints Esther M. Alegria to Board contractpharma
July 05, 2021
Avid Bioservices, Inc., a dedicated biologics CDMO, has appointed Esther M. Alegria, Ph.D., as an independent member of the company’s board of directors.
Hermes Pharma Announces Spin-out from Hermes Arzneimittel contractpharma
July 05, 2021
CDMO specializes in the development and manufacture of user-friendly oral dosage forms for healthcare companies around the world.
Fujifilm Invests $850M to Expand Biologics Capabilities contractpharma
July 02, 2021
Investment in CDMO business to add development and manufacturing capacity in US and UK.
Fujifilm Diosynth Biotechnologies to expand biologics manufacturing capacity cphi-online
July 01, 2021
As part of $850 million investment package, CDMO will double US cell culture production for recombinant vaccines and increase UK gene therapy production tenfold.
WuXi STA Chooses Middletown Delaware for New Pharma Manufacturing Campus contractpharma
June 30, 2021
The CDMO is bringing about 500 jobs to Middletown, site expected to open in 2024.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page